specielt D2- receptorantagonister bør ske med forsigtighed, og patienten bør følges omhyggeligt for aftagende antiparkinson- effekt eller forværring af parkinson- symptomer.
particularly D2 receptor antagonists should be carried out with caution, and the patient carefully observed for loss of antiparkinsonian effect or worsening of parkinsonian symptoms.